Quarterly report pursuant to Section 13 or 15(d)

Stock Compensation Plan (Tables)

v3.24.1.1.u2
Stock Compensation Plan (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted Average

Remaining Contractual

Term (In Years)

   

Aggregate

Intrinsic Value(1)

 
Outstanding at December 31, 2023     244,733     $ 20.17       7.96     $  
Granted                     $  
Exercised                     $  
Forfeited     (2,919 )     19.57       6.49     $  
Outstanding at March 31, 2024     241,814     $ 38.30       7.50     $  
                                 
Exercisable at March 31, 2024     179,514     $ 25.36       7.36     $  

 

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2023 and March 31, 2024; respectively.
Schedule of Restricted Stock Activity

Restricted stock grant activity during the quarter ended March 31, 2024 was as follows:

 Schedule of Restricted Stock Activity

    Number of Shares    

Weighted Average

Grant Date

Fair Value

 
Non-vested restricted stock at December 31, 2023     6,000     $ 3.37  
Vested     (6,000 )     3.37  
Non-vested restricted stock at March 31, 2024         $